Focus: Royal Biologics is a public biotechnology company specializing in autologous and live cell therapies, headquartered in Hackensack, NJ. The company focuses on advanced wound care and regenerative medicine applications.
Profile data last refreshed 44m ago · AI intelligence enriched 1w ago
Growing — net +6 jobs in 30d
21 jobs added vs 15 removed. Steady team buildout.
Royal Biologics is a speculative opportunity for specialists in cell therapy commercialization, but limited hiring and pipeline breadth present career growth uncertainties.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Royal Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Royal Biologics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles